Stock AGE SERINA THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Serina Therapeutics, Inc.

Equities

AGE

US81751A1088

Market Closed - Nyse
Other stock markets
 04:00:00 2024-05-31 pm EDT 		5-day change 1st Jan Change
9.41 USD -0.95% Intraday chart for Serina Therapeutics, Inc. -4.37% -.--%
May. 15 Enable Injections and Serina Therapeutics Announce Agreement to Develop SER-252 in Combination with enFuse® for Advanced Parkinson?s Disease CI
Apr. 17 Serina Therapeutics, Inc. Appoints Simba Gill as Executive Chairman CI

Summary

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Enable Injections and Serina Therapeutics Announce Agreement to Develop SER-252 in Combination with enFuse® for Advanced Parkinson’s Disease
AQ
Enable Injections and Serina Therapeutics Announce Agreement to Develop SER-252 in Combination with enFuse® for Advanced Parkinson?s Disease
CI
Serina Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Highlights
AQ
Serina Therapeutics Appoints Dr. Simba Gill as Executive Chairman
AQ
Serina Therapeutics, Inc. Appoints Simba Gill as Executive Chairman
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. AGE Stock
  4. News Serina Therapeutics, Inc.